| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A call for better understanding of target engagement in Tau antibody development
|
Bespalov, Anton
|
|
|
27 |
11 |
p.
|
artikel
|
| 2 |
Adipokines as targets in musculoskeletal immune and inflammatory diseases
|
González-Rodríguez, María
|
|
|
27 |
11 |
p.
|
artikel
|
| 3 |
Advancement of cell-penetrating peptides in combating triple-negative breast cancer
|
Fatima, Mahak
|
|
|
27 |
11 |
p.
|
artikel
|
| 4 |
Annexins as potential targets in ocular diseases
|
André da Silva, Rafael
|
|
|
27 |
11 |
p.
|
artikel
|
| 5 |
Biopharmaceutical R&D outsourcing: Short-term gain for long-term pain?
|
Billette de Villemeur, Etienne
|
|
|
27 |
11 |
p.
|
artikel
|
| 6 |
Clinical significance and potential role of trimethylamine N-oxide in neurological and neuropsychiatric disorders
|
Mudimela, Sowjanya
|
|
|
27 |
11 |
p.
|
artikel
|
| 7 |
Combining DELs and machine learning for toxicology prediction
|
Blay, Vincent
|
|
|
27 |
11 |
p.
|
artikel
|
| 8 |
Concepts and applications of chemical fingerprint for hit and lead screening
|
Yang, Jingbo
|
|
|
27 |
11 |
p.
|
artikel
|
| 9 |
Contents page
|
|
|
|
27 |
11 |
p.
|
artikel
|
| 10 |
COVID-19 and fibrosis: Mechanisms, clinical relevance, and future perspectives
|
Saifi, Mohd Aslam
|
|
|
27 |
11 |
p.
|
artikel
|
| 11 |
Digital biomarkers for post-licensure safety monitoring
|
Garcia-Gancedo, Luis
|
|
|
27 |
11 |
p.
|
artikel
|
| 12 |
Drug counterfeiting and decentralized whistleblowers
|
Omidian, Hossein
|
|
|
27 |
11 |
p.
|
artikel
|
| 13 |
Emergent treatments for β-thalassemia and orphan drug legislations
|
Costa, Enrico
|
|
|
27 |
11 |
p.
|
artikel
|
| 14 |
Evaluating molecular fingerprint-based models of drug side effects against a statistical control
|
Alpay, Berk A.
|
|
|
27 |
11 |
p.
|
artikel
|
| 15 |
Generic dry powder inhalers bioequivalence: Batch–to-batch variability insights
|
Salama, Rania
|
|
|
27 |
11 |
p.
|
artikel
|
| 16 |
Nanomedicine approaches to reduce cytokine storms in severe infections
|
Ahmar Rauf, Mohd
|
|
|
27 |
11 |
p.
|
artikel
|
| 17 |
Omics technologies to understand drug toxicity mechanisms
|
Nguyen, Nhan
|
|
|
27 |
11 |
p.
|
artikel
|
| 18 |
Pharmacogenetics of human sulfotransferases and impact of amino acid exchange on Phase II drug metabolism
|
Isvoran, Adriana
|
|
|
27 |
11 |
p.
|
artikel
|
| 19 |
Potential nanocarrier-mediated miRNA-based therapy approaches for multiple sclerosis
|
Trideva Sastri, K.
|
|
|
27 |
11 |
p.
|
artikel
|
| 20 |
Recent insights into viral infections as a trigger and accelerator in alzheimer's disease
|
De Vlieger, Lize
|
|
|
27 |
11 |
p.
|
artikel
|
| 21 |
Self-amplifying mRNA vaccines: Mode of action, design, development and optimization
|
Pourseif, Mohammad M.
|
|
|
27 |
11 |
p.
|
artikel
|
| 22 |
Senotherapies: A novel strategy for synergistic anti-tumor therapy
|
Qi, Xuxin
|
|
|
27 |
11 |
p.
|
artikel
|
| 23 |
Successes and failures of immunotherapy for gastric cancer
|
Wang, Jianzheng
|
|
|
27 |
11 |
p.
|
artikel
|
| 24 |
The current status of COVID-19 vaccines. A scoping review
|
Rueda-Fernández, Manuel
|
|
|
27 |
11 |
p.
|
artikel
|
| 25 |
Trading places: Peptide and small molecule alternatives to oligonucleotide-based modulation of microRNA expression
|
Chaudhry, Talhat
|
|
|
27 |
11 |
p.
|
artikel
|
| 26 |
Use of cholesterol metabolism for anti-cancer strategies
|
Ediriweera, Meran Keshawa
|
|
|
27 |
11 |
p.
|
artikel
|
| 27 |
Utilizing public and private sector data to build better machine learning models for the prediction of pharmacokinetic parameters
|
Kuroda, Masataka
|
|
|
27 |
11 |
p.
|
artikel
|
Tijdschrift beschrijving